CN102895444A - Traditional Chinese medicine composition for treating lithangiuria - Google Patents

Traditional Chinese medicine composition for treating lithangiuria Download PDF

Info

Publication number
CN102895444A
CN102895444A CN201210323003XA CN201210323003A CN102895444A CN 102895444 A CN102895444 A CN 102895444A CN 201210323003X A CN201210323003X A CN 201210323003XA CN 201210323003 A CN201210323003 A CN 201210323003A CN 102895444 A CN102895444 A CN 102895444A
Authority
CN
China
Prior art keywords
parts
herba
chinese medicine
radix
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210323003XA
Other languages
Chinese (zh)
Other versions
CN102895444B (en
Inventor
刘长灵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210323003.XA priority Critical patent/CN102895444B/en
Publication of CN102895444A publication Critical patent/CN102895444A/en
Application granted granted Critical
Publication of CN102895444B publication Critical patent/CN102895444B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a traditional Chinese medicine composition for treating lithangiuria. The traditional Chinese medicine composition is prepared from the following raw material drugs, by weight, 100 parts of gordon euryale seed, 100 parts of lotus seed, 100 parts of cowherb seed, 45-55 parts of japanese climbing fern spore, 45-55 parts of christina loosestrife herb, 45-55 parts of tangerine peel, 45-55 parts of largehead atractylodes rhizome, 8-10 parts of asiatic plantain herb, 8-10 parts of eucommia bark, 14-16 parts of herba epimedii, 18-22 parts of dandelion, 18-22 parts of prepared rhizome of rehmannia, 14-16 parts of Chinese taxillus herb, 14-16 parts of radix dipsaci from Sichuan of China, 11-13 parts of safflower, 11-13 parts of salvia miltiorrhiza, 11-13 parts of corydalis tuber, 9-11 parts of frankincense, 9-11 parts of myrrh, 14-16 parts of oldenlandia, 9-11 parts of dragon's blood, 9-11 parts of Chinese honeylocust spine, 9-11 parts of sappsn wood, 9-11 parts of cynodon dactylon, 4-6 parts of talc, 14-16 parts of immature tangerine fruit, 14-16 parts of franchet groundcherry calyx or fruit, and 14-16 parts of rheum. According to the traditional Chinese medicine composition, various raw material drugs are coordinated so as to provide drug efficacy to the maximal degree, and effects of heat clearing, detoxication, diuresis, kidney ureter peristalsis improvement, litholysis, good lithangiuria treatment effect, rapid effect, no toxic and side-effect, and lithangiuria formation prevention are provided.

Description

A kind of Chinese medicine composition for the treatment of lithangiuria
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of lithangiuria.
Background technology
All calculus that occurs at human body renal pelvis, ureter, bladder, urethra are referred to as urinary system calculus, also claim urinary calculus.Urinary calculus is global commonly encountered diseases, and is also higher at the sickness rate of China, and is mainly in person between twenty and fifty.Long-term lithangiuria is large especially to the harm of health, and the method for existing treatment cholelithiasis mostly is modus operandi and oral western medicine, performs the operation very big to patient's actual bodily harm, and the oral western medicine effect is bad, also has simultaneously side effect.
Summary of the invention
The invention discloses a kind of Chinese medicine composition for the treatment of lithangiuria, this Chinese medicine composition has the effect of heat-clearing and toxic substances removing, diuresis, simultaneously can promote kidney, ureteral wriggling, the effect that also has lithodialysis, treatment lithangiuria good effect, instant effect, without any side effects, have simultaneously the effect of the formation of prevention lithangiuria.
The technical solution used in the present invention is as follows:
A kind of Chinese medicine composition for the treatment of lithangiuria, it is characterized in that, made by following crude drug, the weight portion of each crude drug is: Semen Euryales 100, Semen Nelumbinis 100, the king does not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 45-55, Pericarpium Citri Reticulatae 45-55, Rhizoma Atractylodis Macrocephalae 45-55, Herba Plantaginis 8-10, Cortex Eucommiae 8-10, Herba Epimedii 14-16, Herba Taraxaci 18-22, Radix Rehmanniae Preparata 18-22, Herba Taxilli 14-16, Radix Dipsaci 14-16, Flos Carthami 11-13, Radix Salviae Miltiorrhizae 11-13, Rhizoma Corydalis 11-13, Olibanum 9-11, Myrrha 9-11, Herba Hedyotidis Diffusae 14-16, Sanguis Draxonis 9-11, Spina Gleditsiae 9-11, Lignum Sappan 9-11, Bermuda grass 9-11, Talcum 4-6, Pericarpium Citri Reticulatae Viride 14-16, Calyx Seu Fructus Physalis 14-16, Radix Et Rhizoma Rhei 14-16.
The Chinese medicine composition of described treatment lithangiuria, it is characterized in that, be comprised of following component, the weight portion of each component is: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Herba Plantaginis 9, the Cortex Eucommiae 9, Herba Epimedii 15, Herba Taraxaci 20, Radix Rehmanniae Preparata 20, Herba Taxilli 15, Radix Dipsaci 15, Radix Salviae Miltiorrhizae 12, Rhizoma Corydalis 12, Olibanum 10, Myrrha 10, Herba Hedyotidis Diffusae 15, Sanguis Draxonis 10, Spina Gleditsiae 10, Lignum Sappan 10, Bermuda grass 10, Talcum 5, Pericarpium Citri Reticulatae Viride 15, Calyx Seu Fructus Physalis 15, Radix Et Rhizoma Rhei 15.
Described Chinese medicine composition is characterized in that: can be prepared into according to the method for Chinese medicinal of routine any oral formulations commonly used.
Described Chinese medicine composition is characterized in that: described oral formulations can be pill, capsule, tablet, powder, granule or oral liquid.
Usage and dosage: dosage of the present invention depends on concrete dosage form, the factors such as patient age, body weight, health status.General Requirements is:
For oral administration: 1) capsule: every day three times, each serving 2~5, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The various crude drug of Chinese medicine composition of the present invention are mutually coordinated can play together and are at utmost brought into play drug effect, effect with heat-clearing and toxic substances removing, existing diuresis, can increase again kidney, ureteral wriggling function, the effect of lithodialysis is arranged again, treatment lithangiuria good effect, instant effect, without any side effects, have simultaneously the effect of formation of prevention lithangiuria.But the self-coordination ability of Effective Raise patient body is significantly improved function and clinical subjective symptoms.
The specific embodiment
Further describe by the following examples the present invention, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
Embodiment 1: the preparation of capsule
Take by weighing each raw material (g) by following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Herba Plantaginis 9, the Cortex Eucommiae 9, Herba Epimedii 15, Herba Taraxaci 20, Radix Rehmanniae Preparata 20, Herba Taxilli 15, Radix Dipsaci 15, Radix Salviae Miltiorrhizae 12, Rhizoma Corydalis 12, Olibanum 10, Myrrha 10, Herba Hedyotidis Diffusae 15, Sanguis Draxonis 10, Spina Gleditsiae 10, Lignum Sappan 10, Bermuda grass 10, Talcum 5, Pericarpium Citri Reticulatae Viride 15, Calyx Seu Fructus Physalis 15, Radix Et Rhizoma Rhei 15.
Be ground into after each component mixing with above-mentioned weight and incapsulate and get final product after fine powder is crossed 1500 mesh sieves.
Embodiment 2: the preparation of granule
Take by weighing each raw material (g) by following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 45, Herba Lysimachiae 55, Pericarpium Citri Reticulatae 45, the Rhizoma Atractylodis Macrocephalae 55, Herba Plantaginis 8, the Cortex Eucommiae 10, Herba Epimedii 14, Herba Taraxaci 22, Radix Rehmanniae Preparata 18, Herba Taxilli 16, Radix Dipsaci 14, Flos Carthami 13, Radix Salviae Miltiorrhizae 13, Rhizoma Corydalis 13, Olibanum 11, Myrrha 11, Herba Hedyotidis Diffusae 16, Sanguis Draxonis 11, Spina Gleditsiae 11, Lignum Sappan 11, Bermuda grass 11, Talcum 6, Pericarpium Citri Reticulatae Viride 16, Calyx Seu Fructus Physalis 16, Radix Et Rhizoma Rhei 16.
Each raw material of above-mentioned weight fraction is mixed, after being ground into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
Embodiment 3: the preparation of tablet
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Herba Plantaginis 10, the Cortex Eucommiae 10, Herba Epimedii 16, Herba Taraxaci 21, Radix Rehmanniae Preparata 21, Herba Taxilli 16, Radix Dipsaci 16, Radix Salviae Miltiorrhizae 11, Rhizoma Corydalis 11, Olibanum 9, Myrrha 9, Herba Hedyotidis Diffusae 15, Sanguis Draxonis 9, Spina Gleditsiae 9, Lignum Sappan 9, Bermuda grass 9, Talcum 6, Pericarpium Citri Reticulatae Viride 14, Calyx Seu Fructus Physalis 14, Radix Et Rhizoma Rhei 16.
Each raw material of above-mentioned weight portion is mixed, after being ground into fine powder and crossing 800~1200 order dusting covers, make tablet and get final product.
Embodiment 4: the preparation of pill
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 52, Herba Lysimachiae 52, Pericarpium Citri Reticulatae 52, the Rhizoma Atractylodis Macrocephalae 52, Herba Plantaginis 10, the Cortex Eucommiae 10, Herba Epimedii 16, Herba Taraxaci 22, Radix Rehmanniae Preparata 22, Herba Taxilli 16, Radix Dipsaci 16, Radix Salviae Miltiorrhizae 11, Rhizoma Corydalis 11, Olibanum 11, Myrrha 11, Herba Hedyotidis Diffusae 16, Sanguis Draxonis 11, Spina Gleditsiae 11, Lignum Sappan 11, Bermuda grass 11, Talcum 6, Pericarpium Citri Reticulatae Viride 14, Calyx Seu Fructus Physalis 14, Radix Et Rhizoma Rhei 14.
Each raw material of above-mentioned weight is mixed, be ground into cross 600~1000 sieves behind the fine powder after, make pill and get final product.
Embodiment 5: the preparation of oral liquid
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 55, Herba Lysimachiae 55, Pericarpium Citri Reticulatae 55, the Rhizoma Atractylodis Macrocephalae 55, Herba Plantaginis 8, the Cortex Eucommiae 8, Herba Epimedii 14, Herba Taraxaci 18, Radix Rehmanniae Preparata 18, Herba Taxilli 14, Radix Dipsaci 14, Radix Salviae Miltiorrhizae 13, Rhizoma Corydalis 13, Olibanum 11, Myrrha 11, Herba Hedyotidis Diffusae 15, Sanguis Draxonis 10, Spina Gleditsiae 10, Lignum Sappan 10, Bermuda grass 10, Talcum 5, Pericarpium Citri Reticulatae Viride 15, Calyx Seu Fructus Physalis 15, Radix Et Rhizoma Rhei 15.
Each raw material of above-mentioned weight is mixed, after decocting for three times, three filtrates are mixed, filter, be concentrated into the concentration of regulation, cooling, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid and be get final product.
Clinical observation: the present invention carries out clinical observation treatment to 500 routine patients, and the patient is men and women's each age group, the oldest person 75 years old, and the age reckling only has 18 years old, is lithangiuria, shows as lower abdominal pain, hematuria, painful urination, row and does not go out urine etc.Therapeutic Method: oral
1) capsule: every day three times, each serving 2~5, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.30 days is a course for the treatment of.
(1) efficacy assessment standard
Cure: the clinical symptoms sign disappears, and it is normal that functional activity recovers, and pain disappears, and urinates normal, and indices recovers normal on inspection.
Produce effects: the basic or most of disappearance of clinical symptoms sign, pain disappears substantially, urinates slightly not smooth, and majority parameters recovers normal on inspection.
Effectively: the clinical symptoms body is clearly better or takes a turn for the better, pain relief, and urinating slightly gets better turns, and indices slightly take a favorable turn on inspection.
Invalid: clinical symptoms sign thing improves, and Index for examination has no improvement.
(2) therapeutic effect:
The calculus granularity is that 0.1-0.5cm is considered as in early days, and 0.5-0.9cm is considered as mid-term, and 0.9cm is above to be late period.The calculus granularity is 0.1-0.4cm's, takes a course for the treatment of, can cure.For early, 400 patient treatment effects in mid-term are better, can cure general 1-3 course for the treatment of, for the Renal Ureteral Stones in late period through 4-6 the course for the treatment of 40 healings being arranged, 30 produce effects, 20 effective, 10 are invalid.Cure rate 88%, produce effects accounts for, and 6%, effectively account for 7%, invalidly account for 2%, total effective rate 98%.
Model case
1, Zhang, man 35 years old, people from Hefei, No.1 Reople's Hospital, Hefei City was diagnosed as lithangiuria in 2007, taken the some months western medicine result not obvious, in JIUYUE, 2007 adopts the external stone crushing curative effect very little, after begin upon somebody's introduction to take Chinese medicinal granule of the present invention, every day three times, each serving 2~5, every content of dispersion 0.4 gram, warm water takes, cure 4 courses for the treatment of, so far not recurrence.
 
2, grandson, woman, 18 years old, people from Chaohu, on March 24th, 2009 examined, and abdominal pain, hematuria, painful urination, row do not go out urine, be diagnosed as lithangiuria, take pill of the present invention, day takes 1 dose, fries in shallow oil moisture and takes for 2 to 3 times, urinated normal on the 6th day after taking medicine, after continue to take 2 courses for the treatment of of medicine of the present invention, cure the course for the treatment of, so far recurrence.
3, the week certain, man, 75 years old, people from Suzhou, on June 1st, 2009, head examined, and Suzhou City First People's Hospital was diagnosed as lithangiuria in 2009, taken the some months western medicine result not obvious, adopt the external stone crushing curative effect very little in August, 2009, after begin upon somebody's introduction to take Chinese medicinal granule of the present invention, every day three times, each serving 2~5, every content of dispersion 0.4 gram, warm water takes, cure 4 courses for the treatment of, so far not recurrence.

Claims (4)

1. Chinese medicine composition for the treatment of lithangiuria, it is characterized in that, made by following crude drug, the weight portion of each crude drug is: Semen Euryales 100, Semen Nelumbinis 100, the king does not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 45-55, Pericarpium Citri Reticulatae 45-55, Rhizoma Atractylodis Macrocephalae 45-55, Herba Plantaginis 8-10, Cortex Eucommiae 8-10, Herba Epimedii 14-16, Herba Taraxaci 18-22, Radix Rehmanniae Preparata 18-22, Herba Taxilli 14-16, Radix Dipsaci 14-16, Flos Carthami 11-13, Radix Salviae Miltiorrhizae 11-13, Rhizoma Corydalis 11-13, Olibanum 9-11, Myrrha 9-11, Herba Hedyotidis Diffusae 14-16, Sanguis Draxonis 9-11, Spina Gleditsiae 9-11, Lignum Sappan 9-11, Bermuda grass 9-11, Talcum 4-6, Pericarpium Citri Reticulatae Viride 14-16, Calyx Seu Fructus Physalis 14-16, Radix Et Rhizoma Rhei 14-16.
2. the Chinese medicine composition for the treatment of lithangiuria according to claim 1, it is characterized in that, be comprised of following component, the weight portion of each component is: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Herba Plantaginis 9, the Cortex Eucommiae 9, Herba Epimedii 15, Herba Taraxaci 20, Radix Rehmanniae Preparata 20, Herba Taxilli 15, Radix Dipsaci 15, Radix Salviae Miltiorrhizae 12, Rhizoma Corydalis 12, Olibanum 10, Myrrha 10, Herba Hedyotidis Diffusae 15, Sanguis Draxonis 10, Spina Gleditsiae 10, Lignum Sappan 10, Bermuda grass 10, Talcum 5, Pericarpium Citri Reticulatae Viride 15, Calyx Seu Fructus Physalis 15, Radix Et Rhizoma Rhei 15.
3. according to claim 1 or 2 described Chinese medicine compositions, it is characterized in that: can be prepared into according to the method for Chinese medicinal of routine any oral formulations commonly used.
4. according to Chinese medicine composition claimed in claim 3, it is characterized in that: described oral formulations can be pill, capsule, tablet, powder, granule or oral liquid.
CN201210323003.XA 2012-09-04 2012-09-04 Traditional Chinese medicine composition for treating lithangiuria Expired - Fee Related CN102895444B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210323003.XA CN102895444B (en) 2012-09-04 2012-09-04 Traditional Chinese medicine composition for treating lithangiuria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210323003.XA CN102895444B (en) 2012-09-04 2012-09-04 Traditional Chinese medicine composition for treating lithangiuria

Publications (2)

Publication Number Publication Date
CN102895444A true CN102895444A (en) 2013-01-30
CN102895444B CN102895444B (en) 2014-07-16

Family

ID=47568130

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210323003.XA Expired - Fee Related CN102895444B (en) 2012-09-04 2012-09-04 Traditional Chinese medicine composition for treating lithangiuria

Country Status (1)

Country Link
CN (1) CN102895444B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104758437A (en) * 2015-03-19 2015-07-08 孙洋平 Traditional Chinese medicine composition for treating kidney stone, preparation method and application thereof
CN104971169A (en) * 2015-08-10 2015-10-14 孙霞 Traditional Chinese medicine for treating urethral calculus
CN105106371A (en) * 2015-09-02 2015-12-02 青岛金智高新技术有限公司 Pharmaceutical composition for treating urinary calculi and application of pharmaceutical composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1730091A (en) * 2005-08-11 2006-02-08 古方安 Medicine for curing lithangiuria
CN101259232A (en) * 2008-04-25 2008-09-10 北京中泰天和科技有限公司 Chinese medicinal composition for treating nephrotic syndrome and preparation thereof
CN101406535A (en) * 2008-11-16 2009-04-15 付继鸿 Chinese medicinal decoction for treating urinary lithiasis
CN102078527A (en) * 2010-12-16 2011-06-01 江鹏 Traditional Chinese medicine formula for treating urinary calculus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1730091A (en) * 2005-08-11 2006-02-08 古方安 Medicine for curing lithangiuria
CN101259232A (en) * 2008-04-25 2008-09-10 北京中泰天和科技有限公司 Chinese medicinal composition for treating nephrotic syndrome and preparation thereof
CN101406535A (en) * 2008-11-16 2009-04-15 付继鸿 Chinese medicinal decoction for treating urinary lithiasis
CN102078527A (en) * 2010-12-16 2011-06-01 江鹏 Traditional Chinese medicine formula for treating urinary calculus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈秦英: "自拟排石汤治疗尿路结石100例", 《实用中医内科杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104758437A (en) * 2015-03-19 2015-07-08 孙洋平 Traditional Chinese medicine composition for treating kidney stone, preparation method and application thereof
CN104971169A (en) * 2015-08-10 2015-10-14 孙霞 Traditional Chinese medicine for treating urethral calculus
CN105106371A (en) * 2015-09-02 2015-12-02 青岛金智高新技术有限公司 Pharmaceutical composition for treating urinary calculi and application of pharmaceutical composition

Also Published As

Publication number Publication date
CN102895444B (en) 2014-07-16

Similar Documents

Publication Publication Date Title
CN101816742A (en) Chinese medicinal composition for treating hemorrhoids and preparation method thereof
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN102526616B (en) Chinese medicinal herb pills for treating cholecystitis and gallstone
CN101766789B (en) Chinese medicine composite for treating appendicitis and preparation method thereof
CN102228603B (en) Chinese medicine for treating retention of urine
CN101961480A (en) Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof
CN104001046A (en) Oral traditional Chinese medicine preparation for treating urinary calculus and preparation method thereof
CN103341064A (en) Chinese medicine composition for treating urine retention
CN102133271A (en) Medicinal tea for curing gout
CN102895444B (en) Traditional Chinese medicine composition for treating lithangiuria
CN101947293A (en) Medicament for treating urinary tract infection and preparation method thereof
CN101810823B (en) Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine
CN101912563B (en) Medicament for treating constipation and preparation method thereof
CN102335300B (en) Stone decomposing and discharging medicament
CN101773649A (en) Chinese medicine composition for treating acute abdomen and preparation method thereof
CN102861288B (en) Traditional Chinese medicine composite for treating kidney stone
CN100548363C (en) Medicine of treatment benign prostate hyperplasia and preparation method thereof
CN101843888A (en) Novel Chinese medicinal composition for treating menorrhagia and a preparation method thereof
CN103610982A (en) Medicine for treating rheumatic arthritis
CN103405574B (en) Medicinal composition for treating hypertension
CN102614344B (en) Traditional Chinese medicine for treating qi-blood deficiency periodontitis, preparation method and administration method thereof
CN101357187A (en) Medicine for treating the prostatitis
CN101433649A (en) Composition for treating gall stone symptom
CN1286515C (en) Medicinal composition for treating cyst
CN110463799A (en) A kind of wild plant composition of protect liver constipation-relieving tea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140716

Termination date: 20170904

CF01 Termination of patent right due to non-payment of annual fee